Optimal antiplatelet therapy for prevention of gastrointestinal injury evaluated by ANKON magnetically controlled capsule endoscopy: Rationale and design of the OPT-PEACE trial
Authors:
- 15 June 2020
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 228, 8-16
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Science and Technology of the People's Republic of China
This publication has 23 references indexed in Scilit:
- Six Versus 12 Months of Dual Antiplatelet Therapy After Implantation of Biodegradable Polymer Sirolimus-Eluting StentCirculation: Cardiovascular Interventions, 2016
- Current Strategies to Reduce Gastrointestinal Bleeding Risk Associated with Antiplatelet AgentsDrugs, 2015
- Magnetic-controlled capsule endoscopy vs. gastroscopy for gastric diseases: a two-center self-controlled comparative trialEndoscopy, 2015
- 2014 ESC/EACTS Guidelines on myocardial revascularizationEuropean Heart Journal, 2014
- Dual Antiplatelet Therapy Over 6 Months Increases the Risk of Bleeding after Biodegradable Polymer‐Coated Sirolimus Eluting Stents Implantation: Insights from the CREATE StudyJournal of Interventional Cardiology, 2014
- Diagnosis of gastrointestinal bleeding: A practical guide for cliniciansWorld Journal of Gastrointestinal Pathophysiology, 2014
- Standardized Bleeding Definitions for Cardiovascular Clinical TrialsCirculation, 2011
- Combination of low-dose aspirin and thienopyridine exacerbates small bowel injuryScandinavian Journal of Gastroenterology, 2010
- Peptic ulcer diseaseThe Lancet, 2009
- Clinical End Points in Coronary Stent TrialsCirculation, 2007